Home » Ats Milano, positive RSA below 0.2% for 5 weeks in a row and zero deaths

Ats Milano, positive RSA below 0.2% for 5 weeks in a row and zero deaths

by admin

Milan, May 28 (beraking latest news Salute) – For 5 consecutive weeks the percentage of suspected or ascertained Covid cases among the guests of the RSA (residential health care homes) of the provinces of Milan and Lodi is less than 0.2%. This was reported by the Ats Metropolitan City of Milan which disclosed the data of the report ‘Covid RSA flow’ updated to 12 May 2021, according to which there are 17 cases out of 13,761 guests (at the survey date) who live in the RSA, or the 0.12%. Also according to the report, there are no new deaths among guests for suspected or confirmed Covid, in the facility or in the hospital, for the fourth consecutive week.

The decrease in infections began as early as December – explains Ats – and, more decisively, from the end of January 2021. “A sign that the vaccination campaign, especially for citizens over 70, is already showing important results “, highlight from the Health Protection Agency.

“These data – explains Walter Bergamaschi, general manager of Ats Metropolitan City of Milan – are the demonstration of the validity of the effects of the vaccination campaign adopted by the Lombardy Region but also certainly of the work of sharing with the managers of the RSA to keep attention on security measures, aimed at reducing the risk of contagion “.

“The vaccination strategies used up to now – reflects Antonio Russo, director of the Uoc Unit of Epidemiology of Ats Milano – have made it possible to achieve extremely high coverage in people over the age of 70, which include most of the RSA guests. . This advantage is certainly modifying the history of the disease and also affects the important reduction in mortality and hospitalization for Covid “.

See also  Malaria: what it is, how it is contracted, how it is treated

COPYRIGHT today © breaking latest news

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy